SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users highlight its association with weed culture and its ambition to mirror Bitcoin's success, with some mentioning a token burn event. The community is actively sharing links to the Weedcoin website and Dexscreener, while also debating its potential and comparing it to other coins. Bullish sentiment is noticeable, with users expressing excitement about its future.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as the market shrugs off government shutdown concerns and continues its climb to new all-time highs, with some analysts pointing to a potential $700 target by year-end. Community discussions focus on the sustainability of the rally, potential pullbacks, and whether current valuations are justified amid economic uncertainty. There's also chatter about specific stocks within the SPY, like TSLA and NVDA.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as the community rallies around the joke-based meme coin on Solana, celebrating its listing on Jupiter and the influx of new holders. Conversations revolve around the classic "What's UpDog?" joke, alongside general bullish sentiment and community pride using the hashtag $WAGMI. The community emphasizes its long-term commitment, locked liquidity, and unique position in the joke meta.

A multi-agent AI platform dissecting human nature’s first principles through iterative survival challenges and data-driven insights. Core dev has access to one of the founding partners of Two Sigma Ventures - the VC company of one of the biggest hedge funds in the world. Plans to raise seed round and scale after building organic foundation. Project devs are from academia space and are trying to bridge the gap between crypto and academia.

CortexZero

CortexZero is gaining traction, with community members highlighting potential breakouts and increased volume. Many are pointing to the token's availability on Phantom Wallet as a key factor, with some suggesting it could be the next big mover in the Solana ecosystem. The crypto community is actively watching for a significant price movement.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amidst discussions about its potential breakout and resistance levels, with the community closely watching for a surge past $3.00. Sentiment is mixed, with some expressing optimism about upcoming ETFs and real-world finance adoption, while others remain skeptical, citing its correlation with Bitcoin's movements and concerns about market manipulation. Traders are actively debating potential price targets and strategies, with some suggesting a bullish outlook while keeping an eye on support levels.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4Chan Crypto is trending as community members discuss recent price action and whale activity, while some debate its long-term potential within the memecoin sector. The community is actively speculating on future price movements, with some expressing bullish sentiment. Broader discussions include its position relative to other meme coins like $PEPE and its connection to internet culture.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders assess its new all-time highs amid a government shutdown and anticipation of Federal Reserve moves. Community discussions revolve around whether the rally can be sustained, with some pointing to AI and tech strength while others express concern about overvaluation. Traders are actively monitoring technical levels and potential pullback scenarios.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines ($LUNR) is trending due to a new NASA contract award, driving speculation about future gains. Community members are actively discussing resistance levels and potential for a short squeeze, with some pointing to bullish technical indicators. The focus remains on $LUNR's role in lunar infrastructure and upcoming catalysts like the LTV contract.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum ($OXY) is trending as investors react to Berkshire Hathaway's purchase of its OxyChem unit for $9.7 billion, with community debate focused on whether this is a strategic move to reduce debt and enable share buybacks, or a concerning sale of a profitable asset at an undervalued price. Some view the transaction as benefiting Berkshire Hathaway more than OXY's shareholders, while others see it as a necessary step to strengthen the company's balance sheet and focus on its core oil and gas operations, noting the potential for debt reduction and future dividend growth.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending due to a newly announced strategic partnership with Perplexity, an AI search company, sparking excitement around potential AI-driven content discovery enhancements. The community is also closely monitoring the high short interest in $RUM, anticipating a potential short squeeze, and some are linking the stock to the upcoming election due to prominent figures associated with the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why GSK (GSK) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Emma Walmsley’s decision to step down as chief executive officer of GSK Plc brings to a close a nearly nine-year tenure, leaving the FTSE 100 with just nine female CEOs.Walmsley will pass the baton to Luke Miels, GSK’s chief commercial officer, on Jan. 1 as it tries to refresh its product pipeline and counter an anticipated expiry of patent protection on its bestselling HIV medicine dolutegravir in 2028.Since taking the top job in 2017, Walmsley has led the company through the Covid-19 pandemic and overseen the spinoff of its consumer health unit into Haleon Plc, as well as doubling the group’s spending on research and development, according to a Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-30/walmsley-s-gsk-exit-leaves-ftse-100-female-ceo-tally-stagnating">report</a>.She also bet big on cancer and respiratory medicines through a series of acquisitions, even as some investors questioned the company’s sluggish share performance and activist fund Elliott Management called for change.“2026 is a pivotal year for GSK to define its path for the decade ahead, and I believe the right moment for new leadership,” Walmsley said in a statement.Her tenure has drawn both admiration and criticism as she was the first woman to lead a global pharmaceutical giant, modernized GSK’s operations, and guided it through turbulent markets, but the company’s stock still fell about 11% under her leadership, The Wall Street Journal&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/business/c-suite/gsk-names-luke-miels-to-succeed-ceo-emma-walmsley-17264317">noted</a>.Her successor, Luke Miels, joined GSK from AstraZeneca in 2017 and is widely seen as instrumental in building the company’s specialty medicines business, particularly in oncology and respiratory treatments.GSK is targeting annual sales of over £40 billion ($53.6 billion) by 2031, compared with £31.4 billion last year. Miels now faces the challenge of proving GSK can hit that goal and restore investor confidence in its drug pipeline and vaccines business.On Stocktwits, retail sentiment for GSK was ‘bullish’ amid ‘normal’ message volume.One user questioned whether Walmsley’s exit would meaningfully change GSK’s long-term prospects, noting that both she and former CEO Andrew Witty had delivered “weak returns” and left the company lagging behind other major drugmakers.&nbsp;The user added that they were uncertain about whether to sell their position but hoped the new leadership could help revive the stock.<stembedurl>https://stocktwits.com/SellHoldBuy/message/630362186</stembedurl><a href="https://stocktwits.com/symbol/GSK">GSK’s U.S.-listed stock</a> has risen 25.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Emma Walmsley, CEO of GSK plc arrives for a reception held for UK and EU businesses at Downing Street on May 19, 2025 in London, England.  (Photo by Peter Nicholls/Getty Images)

GSK’s First Female CEO Steps Down After Nearly A Decade — Retail Hopes New Leadership Can Revive Lagging Stock

Emma Walmsley’s departure comes as GSK works to strengthen its drug pipeline and offset the upcoming loss of patent protection on its top-selling HIV drug, dolutegravir.

Equity

Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock?

Gilead surges 26.5% YTD in 2025 as HIV franchise gains momentum with Yeztugo approval, offsetting cell therapy pressures.

IONS' Rare Neurological Disease Drug Meets Late-Stage Study Goal

Ionis' zilganersen hits its phase III goal in Alexander disease, paving the way for a potential FDA filing in early 2026.

Why GSK (GSK) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

U.S. President Donald Trump on Monday linked autism to both childhood vaccines and the use of Tylenol by pregnant women and children, claims that decades of scientific research have not supported.&nbsp;Meanwhile, Kenvue, the maker of Tylenol, rejected the claims. “We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers,” according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/healthcare-pharmaceuticals/trump-expected-link-autism-with-tylenol-experts-say-more-research-needed-2025-09-22/">report</a>, citing a company statement.&nbsp;Kenvue, which was spun off from Johnson &amp; Johnson in 2023, saw its shares fall 7.5% during Monday’s session to a record low before recovering 4.4% in extended trading.In a White House news conference, Trump repeatedly advised women and parents not to use the painkiller, saying, “Don’t take Tylenol. Fight like hell not to take it,” while acknowledging he was not a doctor.Standing alongside Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, Trump also called for a reexamination of vaccine schedules, urging separate measles, mumps, and rubella shots, and stating that the hepatitis B vaccine should not be administered until age 12, despite longstanding medical guidance recommending it within 24 hours of birth.&nbsp;Tylenol is Kenvue's largest brand, accounting for a mid-to-high single-digit percentage of total sales, The Wall Street Journal&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/healthcare/trump-autism-report-announcement-eb7c90c8?mod=hp_lead_pos1">noted</a>, citing Morningstar. Trump’s warning also comes as Kenvue continues to face litigation over acetaminophen, with hundreds of lawsuits alleging a link to autism or ADHD currently under appeal after a federal judge last year ruled the scientific evidence unreliable.Meanwhile, acetaminophen remains an important option for pregnant women, and vaccines have saved millions of lives, with UNICEF estimating at least 154 million lives preserved over the last 50 years.The Trump administration also announced steps to position leucovorin, a form of folic acid currently used in chemotherapy support, as a treatment for autism-related symptoms.&nbsp;The FDA approved a version of the drug from GSK and cited a review of 40 patients with cerebral folate deficiency, a rare metabolic disorder linked to neurological symptoms. Medicaid coverage for leucovorin will be extended to autism patients, with expectations that private insurers will follow.Researchers reiterated that there is no solid evidence that acetaminophen causes autism. A 2024 study using 2.5 million Swedish children found no causal relationship. In 2025, a review of 46 previous studies was done, which found an association, but it does not show cause and effect.&nbsp;Researchers advised that pregnant women who need acetaminophen should continue taking it at the lowest dose and for the shortest time. Bigger, randomized trials are still needed to determine leucovorin's potential.On Stocktwits, retail sentiment for Kenvue was ‘extremely bullish’ amid ‘extremely high’ message volume.One bullish user said the administration’s comments unfairly singled out Kenvue as if Tylenol were the only acetaminophen brand on the market, adding that people weren’t about to stop using the drug for everyday needs and calling the concerns overblown.<stembedurl>https://stocktwits.com/FatherofTrades/message/629593979</stembedurl>Another user said that they were buying every dip in Kenvue shares and planned to hold through the lawsuits and any eventual settlement.<stembedurl>https://stocktwits.com/StockCapture/message/629592908</stembedurl><a href="https://stocktwits.com/symbol/KVUE">Kenvue’s stock</a> has declined 18.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Kenvue logo is seen displayed on a smartphone screen. U.S. health officials will hold a press conference on autism, which is expected to link Kenvue's Tylenol to the disease. (Illustration by Thomas Fuller/Getty Images)

Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullish

Investors weighed political scrutiny and unproven health claims as Tylenol’s maker faced renewed controversy, sparking volatility in Kenvue’s stock.

Here's Why GSK (GSK) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline 

Roche is set to acquire 89bio for $3.5B, adding late-stage MASH drug pegozafermin to its cardiovascular, renal, and metabolic pipeline. 

GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years

GSK commits $30B to U.S. R&D and manufacturing, with advanced AI-driven biopharma facilities set to expand jobs and innovation.

LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off?

Eli Lilly will invest $5B in a new Virginia plant to make cancer drugs, creating 650 jobs amid Trump's tariff push.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSK Plc - ADR

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

GSK
Glaxosmithkline plc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GSK News

GSK Glaxosmithkline plc - ADR